Position in TMO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,096,036
+$4,237,070 QoQ
Shares Held
12,159
+221.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#780
of 2,602 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $42,339,129 across 32 Diagnostics & Research names. TMO ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
56,486 | $9,931,933 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
12,159 | $6,096,036 | |
| 3 | NTRA |
Natera, Inc.
|
18,839 | $5,113,846 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
23,532 | $4,546,853 | |
| 5 | DHR |
Danaher Corp /De/
|
22,030 | $4,196,274 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
6,259 | $3,314,703 | |
| 7 | A |
Agilent Technologies, Inc.
|
19,198 | $2,550,070 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
1,735 | $913,373 |
All Filings in TMO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,096,036 | 12,159 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,858,966 | 3,782 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,684,722 | 6,359 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,680,069 | 11,711 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,080,550 | 2,665 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,316,649 | 2,646 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,989,359 | 3,824 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,519,207 | 2,456 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,371,440 | 2,480 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,328,064 | 2,285 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,233,555 | 2,324 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,116,610 | 2,206 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $498,792 | 956 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $543,516 | 943 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $516,547 | 938 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $442,269 | 872 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $498,187 | 917 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $569,386 | 964 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $543,133 | 814 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $466,776 | 817 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $419,214 | 831 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $429,914 | 923 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $464,037 | 1,051 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $271,392 | 749 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $143,501 | 506 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||